LSTA
NASDAQ · Biotechnology
Lisata Therapeutics Inc
$5.02
+0.00 (+0.00%)
Open$5.02
Previous Close$5.02
Day High$5.02
Day Low$5.01
52W High$5.07
52W Low$1.81
Volume—
Avg Volume54.2K
Market Cap45.34M
P/E Ratio—
EPS$-2.13
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+535.1% upside
Current
$5.02
$5.02
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.08M | 2.65M | 5.21M |
| Net Income | -21,628,993 | -47,652,616 | -195,079 |
| Profit Margin | -1,998.5% | -1,898.6% | -3.8% |
| EBITDA | -24,342,308 | -56,610,018 | -244,954 |
| Free Cash Flow | — | — | -167,798 |
| Rev Growth | -59.2% | -59.2% | -0.3% |
| Debt/Equity | — | — | 1.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |